{
    "clinical_study": {
        "@rank": "4756", 
        "arm_group": [
            {
                "arm_group_label": "Bio-Oss", 
                "arm_group_type": "Active Comparator", 
                "description": "the xenograft is of bovine origin where the organic phase has been eliminated."
            }, 
            {
                "arm_group_label": "calcium phosphate ceramic", 
                "arm_group_type": "Experimental", 
                "description": "is a calcium phosphate biomaterial"
            }
        ], 
        "brief_summary": {
            "textblock": "This randomized clinical study investigates the efficiency of plasma rich in growth factors\n      (PRGF-Endoret) in combination with bone grafts in the healing of bone and soft tissues after\n      the performance of lateral sinus floor elevation.\n\n      The hypothesis of this study is that the use of PRGF-Endoret will produce similar bone\n      formation regardless the type of bone graft."
        }, 
        "brief_title": "Efficiency of PRGF-Endoret in Combination With a Bone Graft in Lateral Sinus Floor Elevation", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Sinus Floor Augmentation", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients over 18 years\n\n          -  Patients requiring implant prostheses oral rehabilitation.\n\n          -  Patients with insufficient residual height in posterior maxilla requiring a sinus\n             lift procedure to insert the implants\n\n        Exclusion Criteria:\n\n          -  Not having complete the informed consent form.\n\n          -  Sinusitis.\n\n          -  Alcoholism.\n\n          -  Suffering severe haematological disorder or disease.\n\n          -  Be undergoing or having received radiotherapy, chemotherapy or immunosuppressive\n             therapy, corticosteroids and / or anticoagulants, 30 days prior to the study\n             inclusion.\n\n          -  In usual treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) or other\n             anti-inflammatory drugs.\n\n          -  Background of chronic hepatitis or liver cirrhosis.\n\n          -  Diabetes mellitus with poor metabolic control (glycosylated hemoglobin above 9%)\n\n          -  Patients undergoing dialysis.\n\n          -  Presence of malignant tumors, hemangiomas or angiomas in the extraction area.\n\n          -  History of ischemic heart disease in the last year.\n\n          -  Pregnancy or intention to become pregnant during the study follow-up period.\n\n          -  Metabolic bone disease\n\n          -  Patients taking bisphosphonates drugs both orally and intravenously.\n\n          -  In general, any inability to participate in the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01771302", 
            "org_study_id": "BTI-EC/12/Biomat"
        }, 
        "intervention": [
            {
                "arm_group_label": "Bio-Oss", 
                "description": "It is a bone substitute of bovine origin", 
                "intervention_name": "Bio-Oss", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "calcium phosphate ceramic", 
                "description": "It is a synthetic bone substitute ceramic that is composed of calcium and phosphate ions and prepared at high temperature", 
                "intervention_name": "calcium phosphate ceramic", 
                "intervention_type": "Device"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Calcium, Dietary"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "PRGF-Endoret", 
            "Bone graft", 
            "Maxillary sinus", 
            "Vertical bone augmentation"
        ], 
        "lastchanged_date": "January 23, 2013", 
        "location": {
            "contact": {
                "email": "virginia.cuadrado@bti-implant.es", 
                "last_name": "Virginia Caudrado", 
                "phone": "+34945160653"
            }, 
            "facility": {
                "address": {
                    "city": "Vitoria", 
                    "country": "Spain"
                }, 
                "name": "Clinica Eduardo Anitua"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Clinical Trial on the Efficiency of PRGF-Endoret in Combination With a Bone Graft in Lateral Sinus Floor Elevation", 
        "overall_official": {
            "affiliation": "Clinica Eduardo Anitua", 
            "last_name": "Eduardo Anitua, MD, DDS, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The histomorphometrical analysis of the biopsies taken after 6 months of surgical intervention (time for dental implants insertion) will be performed to calculate the primary outcome", 
            "measure": "Percentage of newly-formed bone", 
            "safety_issue": "No", 
            "time_frame": "6 months after surgical intervention"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01771302"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "This data will be measured on the cone-beam CT scanners obtained at baseline and after 6 months of healing", 
                "measure": "Bone density", 
                "safety_issue": "No", 
                "time_frame": "at baseline and after 6 months of intervention"
            }, 
            {
                "description": "At the time of implant insertion and initial insertion torque will be registered", 
                "measure": "Insertion torque", 
                "safety_issue": "No", 
                "time_frame": "6 months after surgical intervention"
            }, 
            {
                "description": "The histological analysis will determine the percentage of residual graft after 6 months of surgery.", 
                "measure": "Percentage of residual graft", 
                "safety_issue": "No", 
                "time_frame": "6 months after surgical intervention"
            }, 
            {
                "description": "This will evaluate the intensity of pain the patient suffered due to the surgical intervention.", 
                "measure": "Pain", 
                "safety_issue": "Yes", 
                "time_frame": "7 days, 15 days, 1 month, 2 months, 6 months and 12 months after surgical intervention"
            }, 
            {
                "description": "This index will evaluate the soft tissue healing.", 
                "measure": "Healing index", 
                "safety_issue": "Yes", 
                "time_frame": "7 days, 15 days and 1 month after surgical intervention"
            }, 
            {
                "description": "Notify the infection of the graft material", 
                "measure": "Infection", 
                "safety_issue": "Yes", 
                "time_frame": "7 days, 15 days, 1 month, 2 months, 6 months and 12 months after surgical intervention"
            }
        ], 
        "source": "Fundaci\u00f3n Eduardo Anitua", 
        "sponsors": {
            "collaborator": {
                "agency": "Biotechnology Institute IMASD", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Fundaci\u00f3n Eduardo Anitua", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}